Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer Female

Explore clinical trials studying Breast Cancer Female. Study availability and eligibility vary by location and protocol.

279 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer Female trial results

Active, Not Recruiting

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

NCT04055493

Conditions
Breast Cancer Female, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Ost-Alb Klinikum Brustzentrum Aalen, Baden-Wurttemberg, Germany
  • Stadtklinik Baden-Baden Brustzentrum Baden-Baden, Baden-Wurttemberg, Germany
  • Kreiskliniken Böblingen Klinikum Böblingen Frauenklinik Böblingen, Baden-Wurttemberg, Germany
  • Uniklinikum Freiburg Frauenklinik Freiburg im Breisgau, Baden-Wurttemberg, Germany
View all 86 locations
View Trial Details
Active, Not Recruiting

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST

NCT04101851

Conditions
Breast Cancer, Breast Cancer Female, Breast Diseases, +5 more
Locations
  • Med. Universität Graz, Frauenklinik Graz, Austria
  • Praxis Dres. Heinrich & Bangerter Augsburg, Germany
  • Universitäts-Klinikum, Frauenklinik Augsburg, Germany
  • Klinikum Mittelbaden Brustzentrum Baden-Baden, Germany
View all 40 locations
View Trial Details
Active, Not Recruiting

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

NCT03384914

Conditions
Breast Cancer Female, Breast Cancer Stage I, Breast Cancer Stage II, +16 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory - Winship Cancer Institute Atlanta, Georgia, United States
  • Indiana University - Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Active, Not Recruiting

Robotic vs. Open NSM for Early Stage Breast Cancer

NCT05720039

Conditions
Breast, Breast Cancer, Breast Cancer Female, +8 more
Locations
  • City of Hope Irvine, California, United States
  • Cedars-Sinai Los Angeles, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)

NCT06100874

Conditions
Breast Cancer Female, Breast Cancer Metastatic, Breast Diseases, +6 more
Locations
  • Miami Cancer Institute at Baptist Health Miami, Florida, United States
  • Dana Farber Cancer Institite Boston, Massachusetts, United States
  • DFCI @ South Shore Hospital South Weymouth, Massachusetts, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details

Related conditions